SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan is a major talking point after its recent strong quarterly performance, which beat analyst expectations and was underpinned by solid results across its diverse business units. Community discussion also centers on CEO Jamie Dimon's optimistic assessment of U.S. economic resilience, alongside the strategic Apple Card portfolio transition, though some are actively debating the potential impact of proposed credit card interest rate caps on the broader financial sector.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is a trending topic following the completion of a significant $1 billion offering to a single institutional investor at a premium, sparking widespread speculation about major strategic acquisitions and accelerated growth. The community is actively discussing upcoming investor events and the company's strong positioning for potential large government contracts in the rapidly expanding drone and counter-drone defense sector, fueling expectations for substantial future upside.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is trending due to a strong quarterly earnings report that largely exceeded expectations, coupled with an optimistic outlook for the coming year. The community highlights the company's successful premium and loyalty strategy, driving robust revenue growth and reinforcing its leadership within the resilient travel sector.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is currently trending with immense bullish sentiment, as the 'Spacemob' community eagerly anticipates updates on key satellite deployments and future launch schedules, alongside the deepening of strategic partnerships with major global telecom and space entities. Discussions highlight ASTS's patented direct-to-device technology as a disruptive force, positioning it uniquely within the rapidly evolving space and defense communication sector, and sparking fierce debate between long-term holders eyeing significant future growth and persistent short interest.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is heavily discussed amid a significant sell-off in natural gas prices, primarily due to warmer-than-anticipated winter weather forecasts reducing heating demand and contributing to an oversupplied market. The community is sharply divided, with many lamenting substantial losses and alleging market manipulation, while a determined subset anticipates a colder shift and potential short squeeze despite the ETF's inherent decay.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is a focal point of discussion, with its stock frequently consolidating around the low $30s amidst a surging AI sector and upcoming earnings. The community is split, with bulls highlighting the company's substantial projected revenue growth, key partnerships for AI infrastructure, and a recent credit facility as signs of deep undervaluation. Conversely, bears remain concerned about margin pressures, past accounting issues, and perceived management shortcomings, contributing to intense debate over the stock's delayed breakout despite broad market strength.

L3Harris Technologies, Inc. engages in the provision of defense and commercial technologies across the air, land, sea, space, and cyber domains. It operates through the following segments: Space and Airborne Systems, Integrated Mission Systems, Communication Systems, and Aerojet Rocketdyne. The Space and Airborne Systems segment provides full mission solutions as a prime and subsystem integrator in the space, airborne and cyber domains. The Integrated Mission Systems segment focuses on the differentiated mission capabilities and prime systems integration for the air, land and sea domains. The Communication Systems segment enables warfighters across all domains with solutions critical to mission success even in the most contested environments. The Aerojet Rocketdyne segment includes propulsion, power and armament products and systems to U.S. government, including the DoD, National Aeronautics and Space Administration (“NASA”) and major aerospace and defense prime contractors. The company was founded in 1890 and is headquartered in Melbourne, FL.

L3Harris Technologies Inc

L3Harris Technologies is trending amid plans for an IPO of its Missile Solutions unit, sparking community discussion about defense tech growth opportunities. This move, coupled with recent major contract wins for advanced missile tracking and electronic warfare systems, and a strategic partnership with Palantir, positions the company strongly within the burgeoning global defense spending and high-tech military landscape.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Nano Nuclear Energy is actively discussed amidst a burgeoning nuclear sector, fueled by urgent AI data center power demands and favorable regulatory tailwinds. The company is trending following recent milestones, including a federal lawsuit dismissal, acquisition news, commencement of drilling for its KRONOS microreactor, and substantial institutional investment, though community debate on its valuation and dilution persists. Investors are closely watching its progress in developing microreactors to address the critical need for clean, reliable energy solutions.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its highly engaged community champions the "OG meme" narrative of Rage Comics, positioning it as a "foundational meme reset" for the current market cycle. This dedicated base actively builds an ecosystem with platforms like RageMaker and RageGames, expressing strong conviction and urging fellow enthusiasts to "Return to the Memes" and "Rage On" to reclaim leadership in the meme coin space.

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Travere Therapeutics Inc

Travere Therapeutics (TVTX) is trending due to intense investor speculation surrounding an upcoming FDA decision for its kidney therapy, FILSPARI, in Focal Segmental Glomerulosclerosis (FSGS). The community is sharply divided, with discussions fueled by notable insider selling and recent FDA requests for additional data, leading some to predict a regulatory setback while others aggressively buy the dip, anticipating a potential first-ever approval for FSGS.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ALT Yesterday’s MASH-TAG presentation by Dr. Mazen Noureddin delivered a far more detailed, mechanism-level view of pemvidutide’s histologic and antifibrotic effects, validated by one of the most respected leaders in the MASH field, clearly demonstrating that the market significantly mispriced and over-penalized Altimmune after the earlier press releases.

robust8Billion

thaines1

Groggok

hrheasy

Noodles

Better DAYS

Chris

Jack

golfeveryday

SoYeon

Mary OReilly

Brad Sutton

Hervé Dupraz-Fraizier

DrButtCheeks

G. Body

Walter

VINCE_CARTER

PAUL ROGER

BigElvis_GTown

Kevin Day

GoTime

Mark (Buzz)

denzel d

BigCheeze

Jim Reader

Diggs

$ALT I missed the presentation but nice to see a presentation dedicated to pemvi only from Mazen Noureddin at the infkuenctual MASHTAG conference. Only other molecule to get a standalone presentation was efuxifermin.

Very similar to AASLD late breaker podium presentation. Great exposure in front of KOLs and many big pharma reps

StockTwits for iOS

Altimmune Inc

Wolvy65

StockTwits Web

 Yesterday’s MASH-TAG presentation by Dr. Mazen Noureddin delivered a far more detailed, mechanism-level view of pemvidutide’s histologic and antifibrotic effects, validated by one of the most respected leaders in the MASH field, clearly demonstrating that the market significantly mispriced and over-penalized Altimmune after the earlier press releases.